Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies ( JBDS ) for Inpatient Care group

Roberts, A., James, J., Dhatariya, K., the Joint British Diabetes Societies (JBDS) for Inpatient Care·2018·Diabetic Medicine
DOI 10.1111/dme.13675

Cited by (158)

Items 101–158 of 158

  1. Prevention of glucocorticoid-induced impairment of bone metabolism—a randomized, placebo-controlled, single centre proof-of-concept clinical trial
    Giulia Gregori, Lisa Johansson, Lena Silberberg, Henrik Imberg, Per Magnusson, Marcus Lind, Mattias Lorentzon · 2025 · JBMR Plus
  2. Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
    Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume J. Stoffels, Amanda Lin · 2019 · American Journal of Therapeutics
  3. Bedeutung von Glukosewerten im Krankenhaus
    M. Jecht · 2022 · Die Diabetologie
  4. Protocolo de evaluación y manejo de efectos adversos del tratamiento esteroideo
    G. Baena-Nieto, Francisco Javier Vílchez López, J.M. Cornejo-Domínguez · 2020 · Medicine - Programa de Formación Médica Continuada Acreditado
  5. Glycemic control in children receiving glucocorticoid therapy
    Alisa Vital'evna Vitebskaya, Попович Анастасия Владимировна, E. Yu. Afonina, Батырева Оксана Владимировна · 2023 · Meditsinskiy sovet = Medical Council
  6. Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
    Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang · 2024 · SAGE Open Medicine
  7. Is there a lack of a glucose monitoring and management protocol for preventing hyperglycemia and glucocorticoid-induced diabetes mellitus in leprosy reactions?
    Douglas Eulálio Antunes, Diogo Fernandes dos Santos, Jaqueline Andreoli Thomazelli, Cassio Martins Leite, Isabela Maria Bernardes Goulart · 2024 · PLoS neglected tropical diseases
  8. The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus
    Nina Alexandrovna Petunina, Narine S. Martirosian, Гончарова Екатерина Валерьевна, Тельнова Милена Эдуардовна, И. А. Кузина, Щетинина Анна Олеговна, Эльмурзаева Эльмира Акрамовна · 2024 · Diabetes Mellitus
  9. Role of Corticosteroids as Adjunctive Therapy in Patients With Odontogenic Cervicofacial Infections: Systematic Review
    Víctor Chumpitaz-Cerrate, Lesly Karem Chávez Rimache, Patrick Guadalupe Aguilar, Claudia A. Gonzales-Camacho, Maricé Maribé Pardavé-Ponce, Angie S. Aponte-Laban, Oskar Eduardo Prada Vidarte · 2025 · Oral Surgery
  10. Steroid-Induced Hyperglycaemia in a Patient With Possible Body Dissatisfaction: A Case Report
    Chukwuebuka Emmanuel Ohakpougwu, Wendy M Bebobru, Emmanuel K. Labram · 2025 · Cureus
  11. Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most
    Morton G. Burt, Faran Khalili, Anjana Radhakutty, Angela Chen · 2026 · Diabetes Obesity and Metabolism
  12. Diabetes Mellitus and Oncology: A Comprehensive Review
    Mayank Kapoor, Amisha Kapoor, Ravi Kant · 2026 · Indian Journal of Medical and Paediatric Oncology
  13. Comorbidity in Graves' Orbitopathy
    Miloš Žarković, Miroslav Knežević · 2017 · KARGER eBooks
  14. Prevalence of Steroid-Induced Hyperglycemia in King Abdulaziz Specialist Hospital, Taif City, Saudi Arabia
    Jehan F Sarriyah, Adel Alghamdi, Norah M. Al-Otaibi, Batool B Abdulrahman, Kholoud M. Aljaed · 2024 · Cureus
  15. The association of hyperglycemia with the development of infectious complications in adult Filipino patients with acute lymphoblastic leukemia
    Preeti Prerna M. Vaswani, Diane Carla Bernardo, Anne Kristine H Quero-Taggaoa, Ma. Cecille Anonuevo-Cruz, Lynn Baquiran Bonifacio · 2021 · Hematology Transfusion and Cell Therapy
  16. Recommendations for Glycemic Treatment for Patients Receiving Dexamethasone for Treatment of COVID-19
    2021 · International Journal of Diabetes and Endocrinology
  17. Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting
    Ricardo Gómez‐Huelgas, Fernando Gómez Peralta · 2022 · Journal of Clinical Medicine
  18. Breastfeeding and diabetes
    Giuliani, C. · 2020 · The Journal of AMD
  19. In‐Hospital Treatment and Surgery in People with Diabetes
    Ketan Dhatariya, Philip Newland‐Jones, Mayank A Patel · 2024
  20. Monitoring and management of patients on therapeutic anticoagulation: A quality improvement initiative
    Anirudh Rao, Prasanna Hanumapura, Kathrine Parker, Siobhan Halligan, Deryn Waring, Michael J. Nash, Alastair J Hutchison · 2019 · Clinical Medicine
  21. Re-audit of bedside glucose monitoring of inpatients on glucocorticoids: have we improved?
    David Bawden, Ranu Baral, Smriti Gaur, Rebecca Rogers, Ketan Dhatariya · 2021 · British Journal of Diabetes
  22. Surveillance of diabetes with inpatients on glucocorticoids: are the JBDS audit standards being met?
    Vaishali Limbachia, Ketan Dhatariya · 2021 · Practical Diabetes
  23. Challenges in Diagnostic and Management of Nephritic Syndrome in Diabetic Nephropathy Patient: a Case Report
    Adinda Dian Novitasari, Nur Samsu · 2021 · Clinical and Research Journal in Internal Medicine
  24. Den glukokortikoidinduzierten Diabetes auf dem Schirm behalten
    Kornelia Konz · 2021 · Info Diabetologie
  25. Den glukokortikoidinduzierten Diabetes auf dem Schirm behalten
    Kornelia Konz · 2021 · CME
  26. Évaluation de la prévention des effets indésirables de la corticothérapie systémique en consultation de médecine interne au CHUGA
    G. Fourcade, M. Lugosi, Laurence Bouillet · 2021 · La Revue de Médecine Interne
  27. Standardised post-steroid glycaemic monitoring on R-CHOP regimen improves long-term risk prevention in a tertiary care centre
    Khin Kay Kay Kyaw · 2022 · Future Healthcare Journal
  28. The mechanisms of hyperglycemia and its management in new coronavirus infection
    В. И. Петров, Olga V. Shatalova, G. M. Glazova · 2023 · Сибирский журнал клинической и экспериментальной медицины
  29. An Old Theme and New Technology: Marked Glucocorticoid-Induced Hyperglycemia in a Hospitalized Patient Uncovered Retrospectively by Her Flash Glucose Monitoring
    Salem Beshyah · 2023 · Journal of Diabetes and Endocrine Practice
  30. Impaired fasting glucose related to cumulative dose of prednisone in patients with leprosy reactions: a glucose monitoring and management protocol
    Jaqueline Andreoli Thomazelli, Diogo Fernandes dos Santos, Cassio Martins Leite, Isabela Maria Bernardes Goulart, Douglas Eulálio Antunes · 2023 · Research Square
  31. Terapéutica no insulínica para los pacientes hospitalizados con diabetes tipo 2
    Abraham Edgar Gracia‐Ramos · 2023 · Salud Jalisco
  32. Diabetes Care in the Oncologic Population
    Lubaina S. Presswala, Azeez Farooki, James Flory · 2023 · Contemporary Endocrinology
  33. Antidiabéticos Não Insulínicos na Abordagem da Hiperglicemia nos Doentes Hospitalizados por Doença Aguda Não Crítica
    Sofia Lopes, Ariana Maia, Pedro Melo, Silvestre Abreu, Isabel Paiva, Luísa Barros · 2024 · Acta Médica Portuguesa
  34. Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
    Н. Т. Ватутин, E. V. Sklyannaya, В. В. Грибов · 2024 · Oncohematology
  35. [Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia].
    Juan Xia, Lijuan DU, Xueli Xi, Zhuping Xu · 2024 · PubMed Central
  36. Steroid therapy in patients with inflammatory bowel disease complicating diabetes diagnosis
    Kinga Knop-Chodyła, Zuzanna Piasecka, Anna Kochanowska-Mazurek, Aneta Głaz, Ewelina Wesołek, Grzegorz Rudzki · 2024 · Quality in Sport
  37. Application Effect of Health Management in Community Diabetic Population
    Honglei Wang, Siqin Ye · 2024 · Journal of Biosciences and Medicines
  38. The impact of insulin requirement on mortality and morbidity in non-diabetic covid-19 patients in the intensive care unit: A retrospective, observational study
    Kadir Yeşildal, Fethi Gültop, Cansu Kılınç Berktaş, Müslüm Akkılıç, Namigar Turgut · 2025 · BMC Anesthesiology
  39. Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy
    Seung Eun Lee, Ju‐Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young-Soon Yoon, Yun Jeong Jeong, Han Seok Choi, Kyoung‐Ah Kim · 2025 · Biomedicines
  40. Real-world glucose-lowering strategies for managing glucocorticoid-induced diabetes in non-intensive hospital settings
    Michela Vergani, Matteo Conti, Alessia Lari, Federico Bertuzzi, Basilio Pintaudi · 2025 · European Journal of Internal Medicine
  41. Impact of Meal Carbohydrate Content on Postprandial Hyperglycemia During Inpatient Use of Fully Automated Insulin Delivery
    Gabija Krutkyte, Nicolas Banholzer, David Herzig, Lia Bally · 2025 · Diabetes Technology & Therapeutics
  42. Dapagliflozin prevents glucocorticoid‐induced hyperglycaemia: Results from the DAPACOID Phase II Clinical Trial
    Erick Josefat Díaz Huerta, German Duarte Bojórquez, Citlalli Guadalupe Hernández-Guzmán, Óscar Noel Chávez Hernández, Claudia Zepeda Moreno, Verónica Edith Velázquez Díaz, Eréndira Pacheco Zavala, Benjamín Sandoval Pérez, Alejandra Álvarez Salinas, Lauro Fabián Amador Medina · 2025 · Diabetes Obesity and Metabolism
  43. Type 2 Diabetes Mellitus and Hyperglycemia Amongst Hospitalized COVID-19 Patients: A Single Center Study from Lebanon
    Mohamad Fleifel, Amal Al Zoghbi, Jana Tabaja, Andrew El Alam, Khaled Abi Farraj, Randa Al Zaatari, Yara Skaff, Rami Tabbikha, Kamar Eid, Rana Attieh et al. · 2025 · SSRN Electronic Journal
  44. Glukokortikoidanwendung und Diabetes mellitus – Pathogenese, Diagnostik und Therapie
    Lea Tschaidse, Matthias K. Auer, Nicole Reisch · 2025 · Diabetologie und Stoffwechsel
  45. Additional file 1 of Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China
    Xu, Yonghao, Ling Sang, Wang, Ya, Li, Zhentu, Wu, Hongkai, Deng, Xilong, Zhong, Nanshan, Liu, Xiaoqing, Li, Shiyue, Li, Yimin · 2024 · Figshare
  46. Hyperglycémies iatrogènes en dehors du virus de l’immunodéficience humaine
    P. Treca, C. Amouyal · 2025 · EMC - Endocrinologie - Nutrition
  47. Type 2 diabetes mellitus and hyperglycemia among hospitalized COVID-19 patients: A single center study from Lebanon
    Mohamad Fleifel, Amal Al Zoghbi, Jana Tabaja, Andrew El Alam, Khaled Abi Farraj, Randa Al Zaatari, Yara Skaff, Rami Tabbikha, Kamar Eid, Rana Attieh et al. · 2025 · Endocrine and Metabolic Science
  48. Crisis hiperglucémica inducida por corticoides
    Diana Paola Cardona Castellanos, Silvia Camila Suárez Castiblanco · 2025 · Revista Repertorio de Medicina y Cirugía
  49. National Survey of the JBDS-IP/UK SACT board guidelines on the management of glycaemia
    Dola Awoyemi, Pinkie Chambers, Daniel L. Morganstein, Ketan Dhatariya, Ruth Board, Nalinie Joharatnam‐Hogan, Elaine Tomlins · 2026 · Research Square
  50. RSSDI clinical practice guidelines for the management of hyperglycemia in hospitalized patients (2025)
    Manoj S Chawla, Vijay Viswanathan, Sanjay Agarwal, Anuj Maheshwari, Rakesh Kumar Sahay, Pratap Jethwani, Sujoy Kumar Ghosh, Sunil Gupta, Nishant Kanodia, A. G. Unnikrishnan et al. · 2026 · International Journal of Diabetes in Developing Countries
  51. Impact of diabetes mellitus in cancer
    Hadrian Noel Alexander F, Sandeep Muzumder, Silpa Mary Johnson, Nirmala Srikantia, Avinash H. Udayashankara, R. Jayalekshmi · 2026 · The Indian Journal of Medical Research
  52. Low‐value glucose monitoring in noncritically ill hospitalized patients
    Niloofar Latifi, Nestoras Nicolas Mathioudakis, Mohammed S. Abusamaan, Megan M. Tschudy, Junjie Ma, S. Olson, Terra Marie M. Jouaneh, Angie Yang, Daniel J. Brotman · 2026 · Journal of Hospital Medicine
  53. Thyroid Eye Disease, Glycemic Control, and the Role of a One-Stop Clinic Approach: A Retrospective Audit Study
    Keiko Carter, Zahid Ullah Khan, Bashir Mahamud, Furhana Hussein, Adnan Abdullah, Godwin Simon, Gideon Mlawa · 2026 · Cureus
  54. Hyperglycemia during ICI Therapy: etiology, risk factors, and survival outcome
    Min Shen, Xinpan Wang, Tianyu Gao, Jiang Yin, Wenxuan Bian, Xuqin Zheng, Tao Yang, Yun Shi · 2026 · Journal of Endocrinological Investigation
  55. Glucocorticoids: an enemy or a friend for the dermatologist? recommendations for proper use and safe discontinuation
    Evangelia Sali, Ioanna A. Paschou, Sofia M. Dimopoulou, Anna Tagka, Vasiliki Chasapi, Electra Nicolaidou, Alexander J. Stratigos, Μelpomeni Peppa, Stavroula Α. Paschou · 2026 · Endocrine
  56. Glucocorticoids and Oral Contraceptives-Induced Hyperglycemia and New Onset Diabetes Mellitus (NODM): Clinical Evidence, Mechanisms, and Management
    Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramanian, Krishnaveni Kandasamy, Mohamed Fahath Shahul Hameed · 2026 · SN Comprehensive Clinical Medicine
  57. GLP ‐1 Receptor Agonist Therapy for Glucocorticoid‐Induced Dysglycaemia: A Systematic Review
    Aleksandra Jędrasek, Wiktoria Ulicka, Karolina Lisowska, Anna Fabiańska, Jolanta Małyszko, Leszek Czupryniak · 2026 · Diabetes Obesity and Metabolism
  58. Sulphonylureas and pioglitazone: still useful for treating diabetes?
    David Morris · 2026 · Independent Nurse